{"id":481323,"title":"Multiple additions to the Prescription Drug List (PDL) [2025-10-30]: Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:23:29.089000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html?wbdisable=true","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-10-30] October 30, 2025 Our file number: 25-107098-682 The purpose of this Notice of Amendment is to announce the addition of belantamab mafodotin, bulevirtide, delgocitinib, deutivacaftor, elinzanetant,…","rawSnapshotUrl":"/api/snapshots/raw/481323","browseUrl":"https://replay.healtharchive.ca/job-6/20260106162329/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html?wbdisable=true#ha_snapshot=481323","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}